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 Abstract 
 Background: The diagnosis of food hypersensitivity (FH) 
in adult patients with gastrointestinal symptoms, beyond 
the immediate IgE-mediated clinical manifestations, is 
very often difficult. The aims of our study were to: 1) eval-
uate the frequency of FH in patients with irritable bowel 
syndrome (IBS)-like clinical presentation; and 2) compare 
the diagnostic accuracy of two different methods of in 
vitro basophil activation tests. 
 Methods: Three hundred and five patients, (235 females, 
age range 18 – 66 years) were included and underwent a 
diagnostic elimination diet and successive double-blind 
placebo-controlled (DBPC) challenges. Two different 
methods of in vitro basophil activation tests (BAT) (CD63 
expression after in vitro wheat or cow ’ s milk protein stim-
ulation) were evaluated: one was performed on separated 
leukocytes, and the other on whole blood. 
 Results: Ninety patients of the 305 studied (29.5%) were 
positive to the challenges and were diagnosed as suffering 
from FH. BAT on separate leukocytes showed a sensitiv-
ity of 86% and a specificity of 91% in FH diagnosis. BAT 
on whole blood showed a sensitivity of 15% – 20% and a 
specificity of 73% in FH diagnosis (p < 0.0001 compared to 
the other method). 
 Conclusions: About one third of the IBS patients included 
in the study were suffering from FH and were cured on 
the elimination diet. The BAT based on CD63 detection on 
whole blood samples did not work in FH diagnosis and 
showed a significantly lower sensitivity, specificity and 
diagnostic accuracy than the assay based on separated 
leukocytes. 
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 Introduction 
 The diagnosis of food hypersensitivity (FH) in adult 
patients with gastrointestinal symptoms, beyond the 
immediate IgE-mediated clinical manifestations, is very 
often difficult. The recent US guidelines recommended 
that the diagnosis of IgE-mediated FH requires both the 
presence of allergen-specific IgE and the development of 
specific symptoms on exposure to that food [ 1 ]. However, 
it is well known that most of the gastrointestinal symp-
toms due to suspect FH lack an IgE-mediated mechanism 
[ 2 ,  3 ] and in these cases no laboratory assay is considered 
useful to make the diagnosis [ 1 ,  3 ]. 
 Patients presenting with irritable bowel syndrome 
(IBS) who are suspected of FH are included in this difficult 
diagnostic category. There is general agreement that some 
of these patients are really affected with FH [ 2 ] as dem-
onstrated by several studies [ 4 – 6 ], but no immunology 
assay is helpful in the diagnosis. A double-blind placebo 
controlled (DBPC) challenge is the gold standard recom-
mended to confirm the suspicion. 
 Very recently, we showed that a cytological assay 
based on in vitro basophil activation after food-antigen 
stimulation had a sensitivity of 86% in the diagnosis of 
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 The present study included patients with IBS diag-
nosis and suspected FH. The aims of the study were to: 
1) evaluate the frequency of FH in patients with IBS-like 
clinical presentation; and 2) compare the diagnostic accu-
racy of two different methods of in vitro basophil activa-
tion tests (BAT). 
Materials and methods 
 Study design 
 The study design contained two parts. In the fi rst retrospective part, 
we included all patients with IBS diagnosis who had undergone DBPC 
challenges for suspected FH, consecutively referred as outpatients to 
the Department of Internal Medicine of the University of Palermo or 
the Internal Medicine of the Hospital of Sciacca, Italy from January 
2007 to June 2011. The inclusion criteria were: 1) age  > 17 years; 2) 
diagnosis of IBS; 3) suspected FH diagnosis evaluated by means of 
DBPC challenges; 4) follow-up duration longer than 12 months aft er 
the initial diagnosis; and 5)  > 1 outpatient visits during the follow-up 
period. 
 Exclusion criteria were: 1) patients with a diagnosis of organic 
gastrointestinal disease; 2) lack of follow-up visits aft er the initial di-
agnosis; and 3) lack of DBPC-challenge method in the FH diagnosis. 
 IBS diagnosis was based on the Rome II criteria for functional 
gastrointestinal disorders [ 8 ]. Furthermore, organic gastrointestinal 
disorders were excluded by an accurate work-up, as previously de-
scribed [ 7 ]. 
 In the second prospective part of the study we called back 20 
patients (15 female, 5 male): 10 of these patients had tested positive at 
the DBPC challenges and 10 had tested negative; they were chosen at 
random from those previously included in the fi rst part of the study. 
All these patients during the fi rst part of the study had undergone the 
in vitro BAT based on the demonstration of altered membrane pheno-
types on allergen-activated basophil, with cytofl uorometric detection 
of CD63 protein, aft er leukocyte separation. During the second part of 
the study they underwent the in vitro BAT based on the same assay 
performed on whole blood; furthermore, they underwent open food 
challenges again. 
 None of the enrolled patients were on any medication or were 
undergoing the elimination diet at the time of the fi rst part of the 
study. They were asked to suspend medications and/or diet at least 
3 weeks before the beginning of the study protocol. 
 The study was conducted in accordance with the principles of 
the Declaration of Helsinki. The study protocol was approved by the 
Ethics Committee of the University Hospital of Palermo and all pa-
tients gave their informed consent to participate. 
 Flow cytometric basophil activation test 
 Aft er enrolment in the fi rst part of the study, the patients underwent 
fl ow cytometric BAT. The assay was performed by diff erent operators, 
unaware of the clinical history of the patients and the results of the 
other tests. 
 From January 2007 to March 2010, the BAT was based for the 
detection of the surface CD63 protein, aft er centrifugation and leu-
kocyte separation (230 patients: 170 females, median age 33.5 years). 
From April 2010 to June 2011 the detection of the surface CD63 pro-
tein was performed on whole blood samples (75 patients: 65 females, 
median age 34 years). Both assays were performed with Flow-CAST  ®  
(B ü hlmann Laboratories AG, Sch ö nenbuch, Switzerland), according 
to the manufacturer ’ s instructions. 
 Flow cytometric basophil activation test  – 
CD63 detection on separate leukocytes 
(old test) 
 The manufacturer ’ s allergens used in all patients were  α -lactalbumin, 
 β -lactoglobulin, casein, and wheat. As a positive control, we used a 
monoclonal Le27 anti-IgE antibody solution (B ü hlmann Laboratories 
AG). As a negative control, only the stimulation buff er containing IL-3 
was used. 
 The blood tubes were centrifuged at 200  g for 5 min at 4 ° C. The 
supernatant containing leukocytes was transferred by pipette into 
polypropylene tubes and centrifuged again at 500  g for 10 min at 4 ° C. 
It was then decanted and the cell pellet was re-suspended in 100  μ L 
of stimulation buff er containing interleukin (IL) 3. The 50  μ L of re-
constituted solutions of allergens were added to 50  μ L of cell suspen-
sion and the tubes incubated for 40 min at 37 ° C. The reaction was 
stopped by adding 100  μ L of cold HEPES buff er (pH 7.3) containing 
EDTA (HEPES 20 m M , NaCl 133 m M , KCl 5 m M , EDTA 0.27 m M ) but 
with no calcium or magnesium (washing buff er) and the tubes were 
centrifuged at 1000  g for 5 min at 4 ° C. The basophils from the cell 
pellet were double-labeled by adding 20  μ L of a mixture of anti-CD63 
phycoerythrin-labeled antibody and anti-IgE fl uorescein isothio-
cyanate (FITC)-labeled antibody. Aft er the incubation for 30 min at 
4 ° C (protected from light exposure), 4 mL of a pre-warmed (18 – 28 ° C) 
erythrolytic reagent (lysing reagent) was added to each tube and left  
at room temperature for 5 ± 1 min. Cell lysis was stopped with 1 mL of 
washing buff er, the tubes centrifuged for 5 min at 1000  g , the super-
natants were decanted and 500  μ L of washing buff er added to each 
tube. The tubes were gently shaken before fl ow-cytometric analysis 
that was performed at once. In each assay, at least 500 basophils 
were counted. 
 In order to defi ne a result as positive, the percentage of baso-
phils activated aft er incubation with antigen should be at least three-
fold the percentage of basophils activated in the background tube. 
When the percentage of basophils activated spontaneously was be-
low 2.5%, we required an additional condition, namely that the per-
centage of basophils activated aft er contact with the antigen should 
be   ≥  5%. These cut-off s were chosen on the basis of receiver operat-
ing characteristic (ROC) curves plotted in our laboratory, enabling us 
to achieve the highest possible sensitivity with optimal specifi city. 
 The intra-assay variation of the test was 3% and was calculated 
from four blood samples taken from two healthy controls and two pa-
tients suff ering from food allergy stimulated with stimulation buff er 
and anti-FceRI Ab and consecutively analyzed 10 times by fl ow cy-
tometry. The inter-assay variation of the test was 6.5% and was calcu-
lated from the blood samples of three healthy controls and three pa-
tients suff ering from food allergy stimulated with stimulation buff er 
and anti-FceRI Ab, analyzed 10 times by fl ow cytometry and re-tested 






Carroccio et al.: A comparison between two different in vitro BAT for gluten- and cow’s milk protein sensitivity       3
 The reproducibility of the assay had been previously reported to 
be excellent: the correlation coeffi  cient, evaluated in 20 patients by 
three expert operators, was equal to 0.92 (p < 0.001) [ 7 ]. 
 Flow cytometric basophil activation test  – 
CD63 detection on whole blood (new test) 
 The blood collected into tubes with EDTA was not centrifuged. Fift y 
microliters of patient ’ s whole blood were added to 3.5 mL polypropyl-
ene tubes for each patient and for each allergen tested and controls, 
then 50  μ L of the corresponding stimulus were transferred by pipette, 
into 100  μ L of stimulation buff er and 20  μ L staining reagent (anti-
CD63 phycoerythrin with anti-CCR3 fl uorescein isothiocyanate). The 
tubes were incubated for 15 min at 37 ° C in a water bath. Aft er the 
incubation 3.5 mL of a pre-warmed (18 – 28 ° C) erythrolytic reagent 
(lysing reagent) was added to each tube and left  at room temperature 
for 5 – 10 min. The tubes were centrifuged for 5 min at 500  g , the super-
natants were decanted, and 500  μ L of washing buff er added to each 
tube. The tubes were gently shaken before fl ow-cytometric analysis 
that was performed at once. In each assay, at least 500 basophils 
were counted. According to the old method of defi ning a result as 
positive, the percentage of basophils activated aft er incubation with 
antigen should be at least three-fold the percentage of basophils acti-
vated in the background tube. When the percentage of basophils ac-
tivated spontaneously was  < 2.5%, we required an additional condi-
tion, namely that the percentage of basophils activated aft er contact 
with the antigen should be   ≥  5%. 
 Wheat and cow ’ s milk proteins 
hypersensitivity diagnoses 
 At entry to the study, those patients who had self-reduced wheat and/
or cow ’ s milk consumption were invited to assume a minimum quan-
tity of 30 g of wheat and 150 mL of cow ’ s milk daily and were ob-
served for 2 – 4 weeks on a regular diet. All patients then commenced 
a standard elimination diet, based on our previous experience [ 7 ,  9 ], 
with the exclusion of wheat, cow ’ s milk, eggs, tomato and chocolate. 
Patients self-reporting FH were also asked to avoid ingestion and/or 
contact with the food(s) causing symptoms. 
 Furthermore, food diaries were maintained by the patients dur-
ing the above periods to assess dietary intake and adherence to the 
diet. 
 Aft er 4 weeks on the elimination diet, those patients who be-
came asymptomatic underwent DBPC challenges. The challenges 
were performed with the reintroduction of a single food at a time; de-
tails about DBPC challenges have been previously published [ 7 ,  10 ]. 
In the case of wheat, the DBPC challenge was performed with cap-
sules coded A or B containing wheat or xylose, respectively. Capsules 
A or B were given for 2 consecutive weeks and then aft er 1 week of 
washout the patients received the other capsules for another 2 weeks 
(cross-over design). 
 During all the phases of the study, including the challenge pe-
riod, the severity of symptoms was recorded: the patients completed 
a 100-mm visual analog scale, with 0 representing no symptoms, 
which assessed overall symptoms and the specifi c symptoms they 
each reported. 
 DBPC challenge for cow ’ s milk proteins was performed with an 
identical method, according to a standard protocol [ 7 ,  10 ], at least 
4 weeks before or aft er wheat challenge and when the VAS score 
was  < 10, on the elimination diet. 
 The challenges were stopped when clinical reactions occurred 
(increase in VAS score  > 30) for at least 2 consecutive days (onset of 
abdominal discomfort or pain, associated with a change in stool fre-
quency and/or appearance). The challenges were considered positive 
if the same symptoms which had been initially presented reappeared 
aft er their disappearance on the elimination diet. 
 Aft er FH had been excluded or confi rmed, all IBS patients were 
invited to continue the follow-up with regular visits every 6 months 
for 1 year. 
 Statistical analysis 
 We followed the STARD checklist for studies on the diagnostic accu-
racy of tests [ 11 ]. Tables were constructed for frequency and percent-
age. The sensitivity, the specifi city and the diagnostic accuracy of the 
immunologic assays, along with their 95% confi dence intervals, were 
calculated by standard statistical methods [ 12 ]. The Fisher ’ s test was 
used to compare the frequencies. To minimize type I errors, p < 0.05 
was considered statistically signifi cant. All statistical analyses were 
performed using the SPSS 11.0 statistical package (Systat Soft ware 
Inc., CA, USA). 
Results 
 First part of the study 
 Three hundred and five patients, (235 females, 70 males, 
age range 18 – 66 years, median age 34 years), fulfilled the 
inclusion criteria and were studied. Of these, 105 became 
asymptomatic on the elimination diet (VAS score  < 10) and 
underwent DBPC challenges. 
 Figure    1 Summary of the challenges results. Seventy 
patients were positive to both wheat and cow ’ s milk 
protein challenge (increase in VAS score  > 30), 12 patients 
were positive to wheat challenge only and eight patients 
were positive to cow ’ s milk protein challenge only. In 
total, 90 patients of the 305 studied (29.5%) were positive 
to the challenges and were diagnosed as suffering from FH 
(FH group). In contrast, a diagnosis of IBS unrelated to FH 
was made in the remaining 215 patients (IBS group). 
 Table    2 shows the results of the fluorometric CD63 
assays on separate leukocytes and on whole blood in the 
IBS and in the FH patients. According to these results, 
 Table    3 shows the sensitivity, specificity and diagnos-
tic accuracy of the two assays in the diagnosis of FH in 
patients with a clinical presentation of IBS. The in vitro 
BAT based on CD63 detection on separate leukocytes 
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 January 2007 – 
March 2010 
 CD 63 detection  160  70 
 April 2010 – 
June 2011 
 CD 203c detection  55  20 
 Table   1  Number of patients studied according to the different 
periods and the BAT methods used. 
 Patients with a final FH diagnosis included cases with both 
wheat and cow ’ s milk protein hypersensitivity and patients with 
hypersensitivity to one of these antigens. 
Q4:
Table 1 is 




showed a higher sensitivity than the same assay on whole 
blood both in cow ’ s milk protein- and wheat hypersensi-
tivity diagnosis (p < 0.0001). In fact, the sensitivity of the 
assay based on whole blood was very low. The specific-
ity of the CD63 on separate leukocyte assay was also sig-
nificantly higher than that of the assay based on whole 
blood (p = 0.0004). As a consequence, the diagnostic accu-
racy in CMP hypersensitivity and in wheat hypersensitiv-
ity diagnoses was significantly higher for the CD63 assay 
on separate leukocytes than for the assay on whole blood 
(p < 0.0001 for both CMP and wheat). 
 No statistical difference in sensitivity and specificity 
was observed for the diagnosis of CMP hypersensitivity 
considering the positive and negative results obtained 
with each different antigen used as in vitro stimulants 
 –  α -lactalbumin,  β -lactoglobulin, casein  – both for the 
assay on separate leukocytes and on whole blood (data 
not shown). 
 Second part of the study 
 All 10 patients who were diagnosed as suffering from FH 
by DBPC challenge during the first part of the study and 
who were included in the prospective second part were 
still on the elimination diet at this time. In fact, they were 
well on the elimination diet and continued to suffer from 
IBS symptoms assuming wheat and/or foods containing 
cow ’ s milk. During this part of the study, they underwent 
open food challenges which confirmed a persistent FH 
diagnosis. 
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  CD63 on separate 
leukocytes 
 CD63 on 
whole blood 
 IBS unrelated to FH  n = 160  n = 55 
 Positive  12  15 
 Negative  148  40 
 IBS related to cow ’ s milk 
protein hypersensitivity 
 n = 58  n = 20 
 Positive  50  3 
 Negative  8  17 
 IBS related to wheat protein 
hypersensitivity 
 n = 62  n = 20 
 Positive  54  4 
 Negative  8  16 
 Table   2  Results of the BAT based on CD63 detection on separate 
leukocytes and of the same assay on whole blood in the patients 
with IBS unrelated to FH and in those suffering with cow ’ s 
milk protein (CMP) hypersensitivity and/or with wheat protein 
hypersensitivity. 
 a Seventy patients were positive to both wheat and cow ’ s milk 
protein challenge, 12 patients were positive to wheat challenge 
only and eight patients were positive to cow ’ s milk protein 
challenge only;  b Upper normal limit for BAT was equal to the 
percentage of basophil activated after incubation with antigen less 
than three-fold the percentage of basophil activated spontaneously; 
 c For CMP hypersensitivity the following antigens were used in the 
BAT:  α -lactalbumin,  β -lactoglobulin, casein; the positivity for one 
or more of the above antigens was considered indicative of  “ BAT 
positivity ” . For wheat hypersensitivity wheat proteins were used for 
the activation test. 
Q5:
+95 CI has 
been rewrit-





  CD63 assay 
on separate 
leukocytes 
 CD63 assay on 
whole blood 
 All IBS patients (n = 120)   
 Sensitivity in cow ’ s milk 
hypersensitivity 
 86% (76% – 93%)  15% (6% – 41%) 
 Sensitivity in wheat protein 
hypersensitivity 
 87% (77% – 93%)  25% (1% – 50%) 
 Specificity  92% (87% – 95%)  73% (60% – 83%) 
 Diagnostic accuracy in cow ’ s 
milk hypersensitivity 
 91% (86% – 94%)  57% (46% – 68%) 
 Diagnostic accuracy in 
wheat hypersensitivity 
 91% (86% – 94%)  59% (68% – 86%) 
 Table   3  Sensitivity, specificity and diagnostic accuracy ( + 95% CI) 
of the immunologic assays in the diagnosis of FH in patients with 
clinical presentation of IBS. 
 Sensitivity of CD63 assay on separate leukocytes versus CD63 on 
whole blood in CMP hypersensitivity: p < 0.0001. Sensitivity of CD63 
assay on separate leukocytes versus CD63 on whole blood in wheat 
hypersensitivity: p < 0.0001. Specificity of CD63 assay on separate 
leukocytes versus CD63 on whole blood: p < 0.0004. Diagnostic 
accuracy of CD63 assay on separate leukocytes versus CD63 
on whole blood in CMP hypersensitivity: p < 0.0001. Diagnostic 
accuracy of CD63 assay on separate leukocytes versus CD63 on 
whole blood in wheat hypersensitivity: p < 0.0001. 
Q6:
+95 CI has 
been rewrit-





 The other 10 patients with IBS, diagnosed as not suf-
fering from FH during the first part of the study as they 
did not improve on the elimination diet or did not worsen 
on DBPC challenges, continued to consume every kind of 
food without restrictions. 
 Table 4 summarizes the results of the in vitro BAT per-
formed with both methods. Using the old method based on 
CD63 detection after leukocyte separation we had found 
two false negative results in eight patients with wheat 
hypersensitivity and one false negative result in eight 
patients with CMP hypersensitivity. When we performed 
the new method based on CD63 detection on whole blood, 
we found a much lower concordance between DBPC chal-
lenge results and CD63 assay results. The specificity of 
both methods was high as no patients who were negative 
to the DBPC challenge were positive to both assays. 
 Discussion 
 Patients suffering from gastrointestinal symptoms and 
suspected FH very often have a difficult clinical history, 
characterized by many consultations and investigations 
without reaching any definite diagnosis. This is the clini-
cal history, in particular, of the patients with IBS-like 
clinical manifestations [ 2 ]. In this respect, the possible 
relationship between IBS and gluten-sensitivity has been 
underlined very recently [ 13 ], although the pathogenesis 
of this condition still remains to be clarified and proba-
bly different subgroups of patients are wrongly included 
under an unique  “ gluten-sensitivity category ” [ 10 ]. The 
major clinical problem in ascertaining whether patients 
with IBS really suffer from GS or FH is the lack of accu-
rate diagnostic assays. These patients could have delayed 
reaction to foods, not IgE-mediated, and obviously none 
of the assays based on the IgE detection can be helpful in 
the diagnosis [ 3 ]. For this reason, in this kind of patient, 
the FH diagnosis must be based on the disappearance of 
symptoms on the elimination diet and a subsequent posi-
tive DBPC challenge. This diagnostic methodology has 
been used in our center for more than 15 years [ 14 ], and 
in the present study we ascertained that about one third 
of the IBS patients included were suffering from FH and 
were cured on the elimination diet. This percentage of 
FH in IBS was almost constant in the different cohorts we 
have studied in recent years [ 6 ,  7 ]. 
 However, the problem of a simpler and less cumber-
some diagnostic approach still exists. Very recently we 
have showed that in IBS-like patients, the assay based 
on the cytofluorometric detection of the in vitro basophil 
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 Patients/sex/age  DBPC challenge results  CD63 assay on separate leukocytes  CD63 assay on whole blood 
 n. 1/F/32 years  Wheat positive/CMP positive  Wheat positive/CMP positive  Wheat negative/CMP negative 
 n. 2/F/30 years  Wheat positive/CMP positive  Wheat positive/CMP positive  Wheat negative/CMP negative 
 n. 3/F/20 years  Wheat positive/CMP positive  Wheat negative/CMP positive  Wheat negative/CMP positive 
 n. 4/F/21 years  Wheat positive/CMP negative  Wheat positive/CMP negative  Wheat negative/CMP negative 
 n. 5/F/38 years  Wheat positive/CMP positive  Wheat positive/CMP positive  Wheat positive/CMP negative 
 n. 6/F/18 years  Wheat positive/CMP negative  Wheat negative/CMP negative  Wheat negative/CMP negative 
 n. 7/F/21 years  Wheat negative/CMP positive  Wheat negative/CMP positive  Wheat negative/CMP positive 
 n. 8/F/38 years  Wheat negative/CMP positive  Wheat negative/CMP positive  Wheat negative/CMP negative 
 n. 9/F/21 years  Wheat positive/CMP positive  Wheat positive/CMP negative  Wheat negative/CMP negative 
 n. 10/F/42 years  Wheat positive/CMP positive  Wheat positive/CMP positive  Wheat positive/CMP negative 
 n. 11/F/19 years  Wheat negative/CMP negative  Wheat negative/CMP negative  Wheat negative/CMP negative 
 n. 12/M/38 years  Wheat negative/CMP negative  Wheat negative/CMP negative  Wheat negative/CMP negative 
 n. 13/M/45 years  Wheat negative/CMP negative  Wheat negative/CMP negative  Wheat negative/CMP negative 
 n. 14/ M/21 years  Wheat negative/CMP negative  Wheat negative/CMP negative  Wheat negative/CMP negative 
 n. 15/F/49 years  Wheat negative/CMP negative  Wheat negative/CMP negative  Wheat negative/CMP negative 
 n. 16/F/38 years  Wheat negative/CMP negative  Wheat negative/CMP negative  Wheat negative/CMP negative 
 n. 17/F/18 years  Wheat negative/CMP negative  Wheat negative/CMP negative  Wheat negative/CMP negative 
 n. 18/M/30 years  Wheat negative/CMP negative  Wheat negative/CMP negative  Wheat negative/CMP negative 
 n. 19/ M/20 years  Wheat negative/CMP negative  Wheat negative/CMP negative  Wheat negative/CMP negative 
 n. 20/F/21 years  Wheat negative/CMP negative  Wheat negative/CMP negative  Wheat negative/CMP negative 
 Table   4  Comparison of BAT results (CD63 detection) performed after leukocyte separation and on whole blood in 10 patients positive to the 
DBPC challenges to wheat and/or CMP and in 10 patients negative to the DBPC challenges. False negative results (discordant towards the 
DBPC results) are marked in Bold. 
activation (CD63 on separate leukocytes) by food antigens 
diagnosed FH with 86% sensitivity, 88% specificity, and 
87% accuracy. This level of sensitivity was significantly 
higher than that of serum total IgE or food-specific IgE 
assays [ 7 ]. These data have determined an increased 
interest for the use of the cytofluorometric assay in FH 
and gluten-sensitive diagnoses and many colleagues 
searching for methodological details have written to us. 
However, the commercial assay which we had used in the 
past changed methods, and since 2010 a new assay on 
whole blood replaced the old assay performed on sepa-
rated leukocytes. This inspired us to perform the present 
study to evaluate the diagnostic accuracy of the two dif-
ferent methods. 
 Our results clearly and surprisingly demonstrated 
that the new BAT based CD63 detection on whole blood 
samples did not work in FH diagnosis. The retrospective 
analysis performed on over 200 patients, all of whom 
underwent DBPC challenges, showed that whereas the 
old test confirmed very good sensitivity (86% – 87%) and 
specificity (91%) in the FH diagnosis, the new test fell to 
a sensitivity of 15% – 20%. This astonishing lack of sensi-
tivity and diagnostic accuracy in FH diagnosis was con-
firmed by the second part of the study, when we called 
back 20 patients who had been previously evaluated with 
the BAT method based on separated leukocytes and tested 
them with the new method performed on whole blood 
samples. In this case also, only two of eight patients with 
CMP hypersensitivity, or with wheat hypersensitivity, 
were positive to the new test. 
 It remains to be clarified what the reasons for such 
an evident fall in diagnostic accuracy could be. It has 
been pointed out that whole blood is less stable and 
functional than the isolated leukocytes, and this consid-
erably reduces its range of use [ 15 ]. Furthermore, it has 
been demonstrated that the presence of allergen-specific 
IgG antibodies in the plasma may influence the results 
[ 15 ]. This could be an important factor in the patients 
we studied as the presence of anti-gliadin IgG antibod-
ies in 50% – 60% of gluten-sensitive, IBS-like patients 
has been demonstrated [ 10 ,  16 ] and we have demon-
strated an evident overlap between patients  “ classified 
as gluten-sensitive ” and those  “ classified as suffering 
from wheat hypersensitivity ” [ 10 ]. Another factor which 
could negatively interfere with the accuracy of the new 
test is the reduced incubation time with the allergens, 
compared to the old test on separate leukocytes (15 min 
vs. 60 min) [ 17 ]. Finally, a direct comparison between 
the technique on whole blood and that on isolated leu-
kocytes has been reported and the latter appeared to be 
more sensitive for allergen-induced basophil CD63 acti-
vation [ 18 ]. 
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 It is evident that the main advantage of using whole 
blood in vitro basophil activation tests would be speed 
and simplicity of manipulation. However, our data 
strongly discouraged its use in FH diagnosis, and induced 
us to reconsider the use of the assay based on isolated leu-
kocytes. The commercial assay currently available did not 
seem to be useful in the complicated diagnostic work-up 
of the suspected FH. 
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